{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T13:55:13Z","timestamp":1789048513494,"version":"build-2803163510"},"reference-count":52,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008805","name":"Federalno Ministarstvo Obrazovanja i Nauke","doi-asserted-by":"publisher","award":["05-35-3210-1\/21"],"award-info":[{"award-number":["05-35-3210-1\/21"]}],"id":[{"id":"10.13039\/501100008805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Medical Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.advms.2023.07.002","type":"journal-article","created":{"date-parts":[[2023,7,19]],"date-time":"2023-07-19T17:41:40Z","timestamp":1689788500000},"page":"258-264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Some pleiotropic effects of statins on hepatocellular carcinoma cells: Comparative study on atorvastatin, rosuvastatin and simvastatin"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1250-6581","authenticated-orcid":false,"given":"Esmeralda","family":"Dautovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Rustemovi\u0107-\u010corbi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahida","family":"Srabovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adaleta","family":"Softi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Smajlovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8018-4326","authenticated-orcid":false,"given":"Maida \u0160ljivi\u0107","family":"Husejnovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4620-3386","authenticated-orcid":false,"given":"Alen","family":"Hatki\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalila","family":"Halil\u010devi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.advms.2023.07.002_bib1","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1016\/j.jacc.2013.08.1626","article-title":"How do statins work? Changing paradigms with implications for statin allocation","volume":"62","author":"Blaha","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.advms.2023.07.002_bib2","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/343425a0","article-title":"Regulation of the mevalonate pathway","volume":"343","author":"Goldstein","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.advms.2023.07.002_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.808712","article-title":"Undertreatment or overtreatment with statins: where are we?","volume":"9","author":"Garc\u00eda-Fern\u00e1ndez-Bravo","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.advms.2023.07.002_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleiotropic effects of statins\u2013basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.advms.2023.07.002_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/cvr\/cvab032","article-title":"Emerging views of statin pleiotropy and cholesterol lowering","volume":"118","author":"Yu","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.advms.2023.07.002_bib6","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1161\/CIRCRESAHA.116.308537","article-title":"Pleiotropic effects of statins on the cardiovascular system","volume":"120","author":"Oesterle","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.advms.2023.07.002_bib7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s44161-022-00023-x","article-title":"The pleiotropic benefits of statins include the ability to reduce CD47 and amplify the effect of pro-efferocytic therapies in atherosclerosis","volume":"1","author":"Jarr","year":"2022","journal-title":"Nature Cardiovascular Research"},{"key":"10.1016\/j.advms.2023.07.002_bib8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1080\/07357900701874658","article-title":"Statin-Induced inhibition of MCF-7 breast cancer cell proliferation is related to cell cycle arrest and apoptotic and necrotic cell death mediated by an enhanced oxidative stress","volume":"26","author":"S\u00e1nchez","year":"2008","journal-title":"Cancer Invest"},{"key":"10.1016\/j.advms.2023.07.002_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1476-0711-11-13","article-title":"Antibacterial activity of statins: a comparative study of Atorvastatin, Simvastatin, and Rosuvastatin","volume":"11","author":"Masadeh","year":"2012","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"10.1016\/j.advms.2023.07.002_bib10","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.metabol.2014.02.014","article-title":"Statin treatment and new-onset diabetes: a review of proposed mechanisms","volume":"63","author":"Brault","year":"2014","journal-title":"Metabolism"},{"key":"10.1016\/j.advms.2023.07.002_bib11","first-page":"10","article-title":"The statins as anticancer agents","volume":"9","author":"Chan","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.advms.2023.07.002_bib12","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/ijc.23242","article-title":"Differences in antitumor effects of various statins on human pancreatic cancer","volume":"122","author":"Gbelcov\u00e1","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.advms.2023.07.002_bib13","doi-asserted-by":"crossref","first-page":"III","DOI":"10.1161\/01.CIR.0000131517.20177.5a","article-title":"Beneficial cardiovascular pleiotropic effects of statins","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.advms.2023.07.002_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165968","article-title":"Pleiotropic effects of statins: a focus on cancer","volume":"1866","author":"Ahmadi","year":"2020","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"key":"10.1016\/j.advms.2023.07.002_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2019.172616","article-title":"Mechanisms of simvastatin myotoxicity: the role of autophagy flux inhibition","volume":"862","author":"Emami","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.advms.2023.07.002_bib16","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1146\/annurev.pharmtox.45.120403.095748","article-title":"Pleiotropic effects of statins","volume":"45","author":"Liao","year":"2005","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.advms.2023.07.002_bib17","doi-asserted-by":"crossref","first-page":"692","DOI":"10.21037\/tlcr.2019.09.08","article-title":"Current perspectives on statins as potential anti-cancer therapeutics: clinical outcomes and underlying molecular mechanisms","volume":"8","author":"Hassanabad","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.advms.2023.07.002_bib18","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00210-016-1252-4","article-title":"Pleiotropic effects of statins: new therapeutic targets in drug design","volume":"389","author":"Bedi","year":"2016","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.advms.2023.07.002_bib19","doi-asserted-by":"crossref","first-page":"8745","DOI":"10.3390\/ijms21228745","article-title":"The role of structure and biophysical properties in the pleiotropic effects of statins","volume":"21","author":"Murphy","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.advms.2023.07.002_bib20","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1126\/science.1059344","article-title":"Structural mechanism for statin inhibition of HMG-CoA reductase","volume":"292","author":"Istvan","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.advms.2023.07.002_bib21","series-title":"Statins in therapy: cellular transport, side effects, drug-drug interactions and cytotoxicity-the unrecognized role of lactones","author":"Fong","year":"2016"},{"key":"10.1016\/j.advms.2023.07.002_bib22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00210-016-1252-4","article-title":"Pleiotropic effects of statins: new therapeutic targets in drug design","volume":"389","author":"Bedi","year":"2016","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"10.1016\/j.advms.2023.07.002_bib23","doi-asserted-by":"crossref","first-page":"4889","DOI":"10.1007\/s13277-015-3551-7","article-title":"The effect of statins on cancer cells\u2014review","volume":"36","author":"Matusewicz","year":"2015","journal-title":"Tumor Biol"},{"key":"10.1016\/j.advms.2023.07.002_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1517\/17425255.2014.851667","article-title":"Evaluation of the pharmacokinetics and drug interactions of the two recently developed statins, rosuvastatin and pitavastatin","volume":"10","author":"Hu","year":"2014","journal-title":"Expet Opin Drug Metabol Toxicol"},{"key":"10.1016\/j.advms.2023.07.002_bib25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00424-003-1168-y","article-title":"Organic anion transporting polypeptides of the OATP\/SLC21 family: phylogenetic classification as OATP\/SLCO superfamily, new nomenclature and molecular\/functional properties","volume":"447","author":"Hagenbuch","year":"2004","journal-title":"Pfl\u00fcgers Archiv"},{"key":"10.1016\/j.advms.2023.07.002_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/0049825031000066259","article-title":"Uptake of rosuvastatin by isolated rat hepatocytes: comparison with pravastatin","volume":"33","author":"Nezasa","year":"2003","journal-title":"Xenobiotica"},{"key":"10.1016\/j.advms.2023.07.002_bib27","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0002-9149(01)01454-0","article-title":"Preclinical and clinical pharmacology of rosuvastatin, a new 3-hydroxy- 3-methylglutaryl coenzyme A reductase inhibitor1","volume":"87","author":"McTaggart","year":"2001","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.advms.2023.07.002_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrendo.2015.194","article-title":"The diabetogenic action of statins \u2014 mechanisms and clinical implications","volume":"12","author":"Betteridge","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.advms.2023.07.002_bib29","article-title":"The role of statins in diabetic retinopathy","author":"Tomkins-Netzer","year":"2022","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.advms.2023.07.002_bib30","doi-asserted-by":"crossref","DOI":"10.2337\/dc09-0738","article-title":"Statin therapy and risk of developing type 2 diabetes: a meta-analysis","volume":"32","author":"Rajpathak","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.advms.2023.07.002_bib31","first-page":"495","article-title":"Effect of statins on fasting plasma glucose in diabetic and nondiabetic patients","volume":"57","author":"Sukhija","year":"2009","journal-title":"J\u00a0Invest Med"},{"key":"10.1016\/j.advms.2023.07.002_bib32","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.3892\/or.2015.3741","article-title":"Statins are potential anticancerous agents","volume":"33","author":"Altwairgi","year":"2015","journal-title":"Oncol Rep"},{"issue":"12","key":"10.1016\/j.advms.2023.07.002_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028813","article-title":"Differential effects of pravastatin and simvastatin on the growth of tumor cells from different organ sites","volume":"6","author":"Menter","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.advms.2023.07.002_bib34","article-title":"Glucose production assay in primary mouse hepatocytes","volume":"2","author":"Matsumoto","year":"2012","journal-title":"Bio Protoc"},{"key":"10.1016\/j.advms.2023.07.002_bib35","first-page":"19","article-title":"Transporter polymorphisms affect normal physiology, diseases, and pharmacotherapy","volume":"13","author":"Sissung","year":"2012","journal-title":"Discov Med"},{"key":"10.1016\/j.advms.2023.07.002_bib36","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s00249-010-0622-y","article-title":"Effect of sodium bicarbonate as a pharmaceutical formulation excipient on the interaction of fluvastatin with membrane phospholipids","volume":"39","author":"Larocque","year":"2010","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.advms.2023.07.002_bib37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1472-8206.2004.00299.x","article-title":"Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update","volume":"19","author":"Schachter","year":"2005","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.advms.2023.07.002_bib38","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.pharmthera.2006.03.003","article-title":"Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: drug\u2013drug interactions and interindividual differences in transporter and metabolic enzyme functions","volume":"112","author":"Shitara","year":"2006","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.advms.2023.07.002_bib39","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3892\/ijmm_00000520","article-title":"Simvastatin inhibits cell growth and induces apoptosis and G0\/G1 cell cycle arrest in hepatic cancer cells","volume":"26","author":"Relja","year":"2010","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.advms.2023.07.002_bib40","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/cancers12030671","article-title":"Statin use and the risk of hepatocellular carcinoma: a meta-analysis of observational studies","volume":"12","author":"Islam","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.advms.2023.07.002_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13046-021-02041-2","article-title":"Statins: a repurposed drug to fight cancer","volume":"40","author":"Jiang","year":"2021","journal-title":"J\u00a0Exp Clin Cancer Res"},{"key":"10.1016\/j.advms.2023.07.002_bib42","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1054\/bjoc.2000.1716","article-title":"Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial","volume":"84","author":"Kawata","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.advms.2023.07.002_bib43","article-title":"Simvastatin-induced cell cycle arrest through inhibition of STAT3\/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells","volume":"8","author":"Wang","year":"2017","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.advms.2023.07.002_bib44","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.lfs.2018.10.002","article-title":"Inhibition of SRC\/FAK cue: a novel pathway for the synergistic effect of rosuvastatin on the anti-cancer effect of dasatinib in hepatocellular carcinoma","volume":"213","author":"El Sayed","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/j.advms.2023.07.002_bib45","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1158\/0008-5472.CAN-19-0644","article-title":"Targeting the metabolic response to statin-mediated oxidative stress produces a synergistic antitumor response","volume":"80","author":"McGregor","year":"2020","journal-title":"Cancer Res"},{"key":"10.1016\/j.advms.2023.07.002_bib46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1080\/15376520590918766","article-title":"Statins and modulation of oxidative stress","volume":"15","author":"Beltowski","year":"2005","journal-title":"Toxicol Mech Methods"},{"key":"10.1016\/j.advms.2023.07.002_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109528","article-title":"In silico interactions of statins with cell death-inducing DNA fragmentation factor-like effector A (CIDEA)","volume":"345","author":"Barreto","year":"2021","journal-title":"Chem Biol Interact"},{"key":"10.1016\/j.advms.2023.07.002_bib48","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s00204-008-0344-4","article-title":"Antioxidative effects of statins","volume":"82","author":"Adam","year":"2008","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.advms.2023.07.002_bib49","first-page":"1313","article-title":"Antioxidant effects of statins by modulating Nrf2 and Nrf2\/HO-1 signaling in different diseases","volume":"11","author":"Mansouri","year":"2022","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.advms.2023.07.002_bib50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2014-000017","article-title":"Statins impair glucose uptake in human cells","volume":"2","author":"Nowis","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"11","key":"10.1016\/j.advms.2023.07.002_bib51","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1097\/FPC.0b013e32834a5585","article-title":"The human primary hepatocyte transcriptome reveals novel insights into atorvastatin and rosuvastatin action","volume":"21","author":"Hafner","year":"2011","journal-title":"Pharmacogenetics Genom"},{"key":"10.1016\/j.advms.2023.07.002_bib52","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1080\/15548627.2015.1091139","article-title":"Chronic HMGCR\/HMG-CoA reductase inhibitor treatment contributes to dysglycemia by upregulating hepatic gluconeogenesis through autophagy induction","volume":"11","author":"Wang","year":"2015","journal-title":"Autophagy"}],"container-title":["Advances in Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1896112623000238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:45:37Z","timestamp":1761824737000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1896112623000238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1896112623000238"],"URL":"https:\/\/doi.org\/10.1016\/j.advms.2023.07.002","relation":{},"ISSN":["1896-1126"],"issn-type":[{"value":"1896-1126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Some pleiotropic effects of statins on hepatocellular carcinoma cells: Comparative study on atorvastatin, rosuvastatin and simvastatin","name":"articletitle","label":"Article Title"},{"value":"Advances in Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.advms.2023.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Medical University of Bialystok. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}